"False"
Umeå University
printicon
Main menu hidden.

Image: Mattias Pettersson

Beatrice Melins group

Research group Brain tumors and especially gliomas are tumors that are not easily cured. The most malignant form glioblastoma have very poor survival.

The etiology of brain tumors is not well known, apart from some genetic factors and ionising radiation. Our group tries to understand the underlying causes of glioma and find biomarkers to detect glioma early. Our overall aim is to gain a deeper understanding of the underlying pattern for the glioma architecture subtypes.

We use both cohort and collected case series from several different studies, such as (U-CAN   and  Northern Sweden Health and disease study

Head of research

Beatrice Melin Professor, senior consultant (attending) physician (on leave), professor, senior consultant (attending) physician
E-mail
Email
Phone
+46 90 786 61 42

Overview

Participating departments and units at Umeå University

Department of Diagnostics and Intervention, The Section of Biobank and Registry Support

Research area

Cancer
Antidepressant drugs and risk of developing glioma: a national registry-based case control study and a meta-analysis
American Journal of Epidemiology, Oxford University Press 2024, Vol. 193, (11) : 1592-1599
Malmberg, Charlotte; Numan Hellquist, Barbro; Sadanandan, Sajna Anand; et al.
Antidepressants and survival in glioma: a registry-based retrospective cohort study
Neuro-Oncology Practice, Oxford University Press 2024, Vol. 11, (2) : 125-131
Edström, Sonja; Numan Hellquist, Barbro; Sandström, Maria; et al.
Blood based metabolic markers of glioma from pre-diagnosis to surgery
Scientific Reports, Springer Nature 2024, Vol. 14
Löding, Sebastian; Antti, Henrik; Sjöberg, Rickard L.; et al.
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
Nature Communications, Springer Nature 2024, Vol. 15, (1)
Went, Molly; Duran-Lozano, Laura; Halldorsson, Gisli H.; et al.
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up
Haematologica, Ferrata Storti Foundation 2024, Vol. 109, (7) : 2359-2363
Pulczynski, Elisa Jacobsen; Simonsen, Mikkel Runason; Kuittinen, Outi; et al.
Altered plasma metabolite levels can be detected years before a glioma diagnosis
JCI Insight, American Society For Clinical Investigation 2023, Vol. 8, (19)
Löding, Sebastian; Andersson, Ulrika; Kaaks, Rudolf; et al.
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts
International Journal of Cancer, John Wiley & Sons 2023, Vol. 152, (9) : 2002-2010
Wu, Wendy Yi-Ying; Haider, Zahra; Feng, Xiaoshuang; et al.
Cancerfonden
New Cancer Fund millions for UMU research

Ten projects at Umeå University receive a total of 30 million SEK from the Swedish Cancer Society.

Extensive study of brain tumor

An Umeå researcher is co-founder of an international team, which has found genetic factors behind glioma.

Knowledge of brain tumour metabolism can improve treatment

Metabolites expression varies greatly between subgroups of malignant brain tumors, cancer researchers show.

Latest update: 2024-08-02